Facebook
X
LinkedIn
Forward
GLP-1 Agonists in Practice: A New Era in Obesity and Diabetes Management
ACTIVITY DESCRIPTION
This activity consists of a recorded presentation from the "Medical Director and Clinician Leadership Forum 2025" held in Nashville, TN., October 22, 2025.
GLP-1 receptor agonists have reshaped the landscape of obesity and type 2 diabetes management, offering benefits beyond glycemic control. This session explores their mechanisms, clinical applications, and emerging evidence on their implications for broader metabolic care and in the treatment of obesity-related conditions such as obstructive sleep apnea.
Provided by
This activity is provided by Optum Health Education.
Commercial support
There was no commercial support received for this activity.
Target Audience
This activity has been designed to meet the educational needs of nurses, nurse practitioners, pharmacists, pharmacy technicians, PAs, physicians, psychologists, social workers and other health care professionals.
Learning Objectives
At the end of this educational activity, participants should be able to:
- Explain the physiological effects of GLP-1 agonists.
- Identify appropriate patient populations for treatment based on current guidelines.
- Evaluate clinical benefits, risks, long-term outcomes and safety considerations.
Faculty
Peminda K. Cabandugama MD, DABOM
Endocrinologist/Obesity Medicine Specialist
Cleveland Clinic
Dr. Cabandugama is board certified in endocrinology, diabetes, and metabolism, and obesity medicine and is a diplomate of the American Board of Obesity Medicine.
He is the current chairman of the clinical practice section of The Obesity Society, as well as a member of The Obesity Society Spokesperson Network. He has also previously served in roles at the Obesity Medicine Association, as well as at the American Board of Obesity Medicine. He is also a founding member and former vice president of the Midwest Obesity Society.
He is the author of book chapters and multiple papers/abstracts on obesity and endocrinology, including work published by the American Diabetes Association, the American Association of Clinical Endocrinology, Medical Clinics of North America, Cleveland Clinic Center for Continuing Education, and Baylor University Medical Center Proceedings.
Dr. Cabandugama has also been featured on multiple media outlets for his medical opinion on obesity and endocrinology including CNN/ABC/NBC/Fox News and its affiliates, Medscape, Nature, JAMA, Vogue, Parade, Health, USAToday, Fortune, Cleveland Clinic News, Healthline, AARP, Verywellhealth, SiriusXM-Doctor Radio, WebMD, Everyday Health and Medical Economics.
He also currently serves as a content and peer reviewer for the Cleveland Clinic Journal of Medicine, Elsevier and the Cureus Journal of Medical Science.
Planners
Elizabeth Albert, MD
Clinical Manager
Optum Health Education
Sarah Chart, RN
Sr. Director Healthcare Optimization & Strategy
Optum Health Education
Sara L. Fleszar, PharmD, BCOP
Senior Clinical Oncology Pharmacist
Whole Health Solutions
Optum Health
Rebecca Gleason, RN, CCM
Clinical Manager
Optum Health Education
Lisa Latts, MD, MSPH, MBA, FACP
Chief Medical Officer
Optum Behavioral Health Solutions & Optum Health Solutions
Optum Health Clinical Excellence
Optum
Jaime Murillo, MD
Senior Vice President and Chief Medical Officer
Medical Affairs
UnitedHealth Group
Sam Nordberg, PhD
Chair of Psychiatry and Behavioral Health
Optum Massachusetts
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Optum Health Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
Financial Relationship Key
A-Advisory Board
CT-Clinical Trial
C-Consultant
E-Employee
G- Grant/Research Support or Funding
I-Stocks and Other Ownership Interests
S-Speakers’ Bureau
O-Other Financial or Material Support
The presenter and planners have no financial relationships to disclose.
Method for calculating CE credit
CE credit was calculated by the complexity of content.
Accreditation statement
In support of improving patient care, this activity has been planned and implemented by Optum Health Education. Optum Health Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit designation statements
This activity was planned by and for the health care team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.
Physicians
Optum Health Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs
The American Academy of PAs (AAPA) accepts credit from organizations accredited by the ACCME.
Pharmacists/Pharmacy technicians
This activity is approved for 1.00 contact hours (0.10 CEUs) in states that recognize ACPE.
Attending the full program will earn 1.00 contact hours (0.10 CEUs).
Unique activity number: JA0007123-0000-25-071-H01-P/T
Nurses
The participant will be awarded up to 1.00 contact hours of credit for attendance and completion of supplemental materials.
Nurse practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Psychologists
Optum Health Education is approved by the American Psychological Association (APA) to offer continuing education for psychologists. Optum Health Education maintains responsibility for this program. 1.00 CE hour.
Social workers
As a Jointly Accredited Organization, Optum Health Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Optum Health Education maintains responsibility for this course. Social workers completing this course receive up to 1.00 enduring continuing education credits.
Attendance
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.
Available Credit
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
You must be logged into your account to participate in this activity. Get started by clicking “Register” and following the instructions. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”